Sherwin-Williams wins U.S. antitrust approval to buy Valspar: FTC
WASHINGTON Paint-maker Sherwin-Williams has won U.S. antitrust approval to buy U.S. rival Valspar Corp , the Federal Trade Commission said on Friday.
Gentiva Health Services Inc GTIV.O said it adopted a poison pill, more than a week after the home healthcare services provider rejected a $533-million hostile bid from hospital operator Kindred Healthcare Inc (KND.N).
Gentiva set a 15 percent trigger for the rights plan, which will expire on May 20, 2015.
Gentiva rejected Kindred's $14-per-share offer on May 15, saying it undervalued the company.
"Poison pills" are designed to stop hostile takeover attempts by triggering the issue of new shares that dilute the holdings of investors who exceed a set threshold.
Gentiva's shares closed at $13.68 on the Nasdaq on Friday. They have gained 60 percent since the offer was made public.
(Reporting By Vrinda Manocha in Bangalore; Editing by Sriraj Kalluvila)
MUNICH German industrial gases group Linde's supervisory board is due to vote on a merger agreement with U.S. peer Praxair on June 1, two people close to the matter told Reuters on Friday.
Soft drink maker PepsiCo Inc is in talks to acquire All Market Inc, the owner of coconut water brand Vita Coco, whose celebrity investors include Madonna and Matthew McConaughey, people familiar with the matter said on Friday.